CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Appoints Renowned Genetics, Cultivation Expert as Advisor

Flora Growth’s (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has named Derek Pedro, an industry-leading cannabis genetics and cultivation expert, as an advisor. Pedro is recognized as a pioneer in the cannabis industry and has consulted on cannabis genetic and cultivation projects around the world, including Canada, the United States, Latin America, Europe and China. In his role at FLGC, he will focus on developing the company’s current register of high-THC and high-CBD strains. The company hopes to offer cannabis flower offerings that are uniquely Colombian to both domestic and international markets. Flora Growth is committed to increasing its cannabis production, and Pedro’s appointment is seen as a way to support the company’s continued adaptation of proven genetics to the unique Colombian climate at one of the lowest cost bases in the world. With more than three decades of experience, Pedro has developed and cultivated hundreds of strains with more than 50 being commercialized within the legal Canadian market; his high-THC strain, called Pedro’s Sweet Sativa, was named top sativa flower in Canada by King Magazine. “As an internationally recognized industry expert and innovative cultivator, the appointment of Derek Pedro aligns perfectly with our goals to optimize our expanding Cosechemos facility operations and increase our varietal offering of cannabis flowers,” said Flora Growth president and CEO Luis Merchan in the press release. “Mr. Pedro has a well-earned reputation as one of the world’s leading experts on cannabis cultivation, and we are thrilled to have him join us as we develop our growing portfolio of brands and expand our global distribution.”

To view the full press release, visit https://cnw.fm/sHRWR

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Moves to Enter Rare Cannabinoid Market Through License Agreement for Patented THC-V-Rich Chemovars

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, today announced its entry into a binding letter of intent (“LOI”) with GenCann Inc., the exclusive licensor for a set of cannabis chemovars particularly rich in the cannabinoid tetrahydrocannabivarin (“THC-V”) (the “GenCann Chemovars”). Under the terms of the LOI, Sugarmade and its licensed cannabis cultivator partners will be granted a five-year license to cultivate what the company believes to be some of the highest THC-V-containing strains in existence. Sugarmade and GenCann plan to begin immediate clone production, upon the signing of the final agreement, with a cultivation program beginning in Lake County, California, this spring. “While THC-V is sometimes referred to as a ‘rare cannabinoid,’ we believe the term no longer applies relative to our planned cultivation effort using GenCann’s Chemovars,” said Jimmy Chan, CEO of Sugarmade. “The test results from certified California laboratories of these chemovars are certainly impressive, with THC-V yields in flower of up to 8%. We think the GenCann Chemovars are a game-changer in the cannabinoid space. Sugarmade plans to make a substantial commitment to bring products based on THC-V to the California market and perhaps to other states in the future. Stay tuned for our upcoming product plan announcements.”

To view the full press release, visit https://cnw.fm/jsA3l

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM), NUG Avenue, Lemon Glow and Budcars. Sugarmade is also the first licensee of the unique and patented GenCann Inc. THC-V rich chemovars. For more information, please visit www.Sugarmade.com.

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — State, Federal Officials Work Together on Draft Cannabis Standardization Proposals

America’s state-legal cannabis industry may be incredibly lucrative, but it is far from perfect. Barely more than a decade old, the sector is known for its patchwork laws and lack of standardization. For quite a while, industry stakeholders and reform activists have argued for the creation of standard rules and procedures. This would make interstate trade possible and allow the industry to really grow. Last week, local, state and federal officials met to discuss proposals that could end up in a federal handbook for cannabis regulation.

Cannabis was on the agenda for two National Conference on Weights and Measures (“NCWM”) committees this past week. If the cannabis-related items that were raised during these meetings are approved in subsequent meetings, they will most likely be incorporated into the National Institute of Standards and Technology’s (“NIST”) federal guidance. A proposal from the Laws and Regulations Committee would establish a standard definition for cannabis and cannabis-infused products, standard requirements for packaging and labeling, and a definition for the water activity range of cannabis.

The proposals for the definition of cannabis and cannabis-infused products as well as the water activity range moved forward and can be adopted into the NIST handbook in July when the committee reconvenes. However, the proposal for the creation of a national standard of weighing marijuana-containing packages didn’t advance and won’t be eligible for addition into the NIST handbook. It will be up for discussion in the future and will most likely be reworked.

The Specifications and Tolerances Committee unveiled a proposal that would create “scale suitability requirements” for selling bulk cannabis to dispensaries in legal states directly. This proposal didn’t advance, and committee members are still working on it.

Text from the proposal states that the need for uniform standards for scale suitability has increased significantly as more states have legalized various forms of cannabis. Uniform requirements across different states will make it much easier for each jurisdiction to regulate their cannabis sector in a “fair and equitable manner,” the proposal claims.

Matthew Curran, food safety director at the Florida Department of Agriculture and Consumer Services, says the country’s state-legal cannabis sector needs standards regulations. The proposals unveiled at the meeting can potentially become the “first national standards” through a national consensus organization with a connection to every state, he says. Standard regulations will provide harmony across state lines, streamline regulation and give sector players such as Cannabis Strategic Ventures Inc. (OTC: NUGS) room to grow.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Four Ways to Benefit from Medical Marijuana in 2022

With medical marijuana legal in 37 U.S. states, chances are high that you could be a resident in one of the states where patients with any of the qualifying health conditions can legally access and use marijuana therapeutically. We discuss below some of the ways through which you can support your health and wellness by incorporating medical cannabis into your routine this year.

Winter aches and pains

Whether your muscles are sore due to several hours spent skiing or engaging in another winter sport, or the bitter cold of the season has made your chronic pain a tad worse, medical marijuana could be of help. Chronic pain is actually one of the qualifying medical conditions for which patients can enroll into the medical marijuana programs in several states where this use of cannabis is legal.

Complementary medicine

Many patients in different states use marijuana either alongside their pharmaceutical medicines or as standalone treatments to manage different symptoms. Since the research on this is still scant, it is best to talk to your doctor first before adding medical marijuana to your treatment plan. The doctor will advise you about any possible drug-on-drug reactions and what you can do about this possibility.

Support mental health

Many health challenges have the potential to trigger anxiety, stress or even depression. The seasonal changes that occur as the year progresses can also trigger mental issues, such as the notorious “winter blues.” Medical marijuana has exhibited the potential to help in managing some of these mental health conditions, and you could also benefit from this potential therapeutic effect.

Alleviate digestive issues

Whether your digestive issues and nausea stem from overindulging in holiday treats or those symptoms are triggered by a medical condition or medication, medical cannabis may help you address those digestive issues. For example, a 2021 study found that marijuana can offer near-immediate relief from nausea.

You have probably heard about the cannabis munchies, and this phenomenon points to marijuana’s potential effects on appetite. It may be worthwhile for you to talk to your doctor if you suffer from digestive issues and think that medical marijuana could be of help.

As you can see, medical marijuana has the potential to help with a number of symptoms that may be afflicting you as 2022 gets underway. If you have a diagnosis for which medical marijuana can be of help in the state where you reside, consult your primary healthcare professional for advice on how to benefit from this versatile plant. Your 2022 may take a turn for the better, especially when you do your homework and identify reputable companies such as Simply Sonoma Inc.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Products Ready for New International Markets

Flora Growth Corp. (NASDAQ: FLGC) is entering 2022 with momentum from the past year’s aggressive growth campaign for its global cannabis-derivative brand distribution of pharmaceuticals, cosmetics and nutraceuticals. While the COVID-19 pandemic has had a deleterious effect on the global sustainability agenda, Flora Growth has prioritized value-chain sustainability among each of its brands, acting at a local level to establish products that will have a beneficial effect on communities and the world at large. Flora’s core product, organic cannabis oil, comes from an inherently sustainable process at the company’s cultivation site in central Colombia. “The company recently began filling the initial orders for its Mind Naturals and Awe CBD skincare brands in Spain and Mexico. They expect to begin distribution of medical cannabis products throughout Europe during the coming year thanks to a pathway established through an investment program with European Union GMP partner Hoshi International Inc.,” a recent article reads. “After months of preparation, our products meet all the needs of today’s consumers, and we are ready for new international markets,” Flora Beauty General Manager Andrew Restrepo stated when the Mind Naturals and Awe CBD orders were announced.

To view the full article, visit https://cnw.fm/CDpMV

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade Inc. (SGMD) Further Verticalizing Model to Drive Shareholder Value Through Margin Gains

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, has made significant progress toward its goal of becoming a central player in the growing California cannabis space. Sugarmade recently announced that its wholly-owned subsidiary, Lemon Glow Company, has received a conditional use permit (“UP”) number from the Community Development Department of Lake County, California — an important step toward full approval to cultivate cannabis on the property. The Lemon Glow property has an annual potential cultivation yield that could reach as much as 4,000 pounds of dry trimmed cannabis flower per acre, or approximately 128,000 pounds or 64 tons. “We are excited to see the process moving forward for our Lemon Glow property, which represents an important strategic asset as we further verticalize our overall model,” stated Sugarmade CEO Jimmy Chan. “Ramping up our cultivation resources is a significant step in fully leveraging a vertical model to drive shareholder value through margin gains.”

To view the full article, visit https://cnw.fm/OD7vK

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue, Lemon Glow, and Budcars. For more information, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Voters Could Decide on Marijuana Measures in 2022 in These States

As the wave to enact cannabis reform gains momentum across the country, we take a look at some of the states in which marijuana ballot measures may be on the cards this year.

In Ohio, advocates who submitted voter signatures last year were told that they needed an additional 13,062 voter signatures to see their initiative cleared by the secretary of state. On Jan. 13, 2022, this group turned in an extra 29,918 voter signatures and now await the verdict of state officials on whether the needed number of valid signatures was attained. The legislature will then have a chance to enact the reform, otherwise the measure will be voted on during this year’s ballot.

In Florida, campaigners are looking to reform the medical marijuana law that was approved by voters back in 2016. One measure is aimed at making changes to the list of the qualifying conditions by adding nine mental health conditions to that list of eligible health conditions if one is to use medical marijuana in the state. Another measure is altering the definition of “medical marijuana use” so that it encompasses the cultivation of a maximum of nine cannabis plants.

In Arkansas, voters may decide the fate of two possible initiatives. One campaign is seeking to legalize recreational cannabis for individuals who are at least 21 years old, while the other initiative is aimed at decriminalizing cannabis, giving limited protections to companies in the cannabis industry and creating regulations to govern the cannabis sector. The deadline for both campaigns to gather at least 89,151 voter signatures is July 8, 2022.

In Idaho, marijuana advocates are back to qualify an initiative to establish a medical cannabis program. Initially, they had wanted to see this initiative on the ballot in 2020, but COVID-19 brought their plans to a halt. However, they promised to return this year. May 1, 2022 is the deadline for the submission of voter signatures in support of this campaign, as well as another campaign designed to end the prohibition of recreational cannabis use by adult residents of the state.

In Oklahoma, there are three measures that could appear on this year’s ballot. Two of these measures are geared to make changes to Oklahoma’s constitution so that a recreational cannabis program can be implemented with sales taxed at 15% while the third measure aims at creating a new regulatory body to replace the current Oklahoma Medical Marijuana Authority.

South Dakota, Missouri and North Dakota also have campaigns underway to put cannabis policy reform measures on this year’s ballot. It remains to be seen which of these initiatives will eventually receiver voter endorsement and become law, thereby expanding the potential market for new and existing sector players such as Flora Growth Corp. (NASDAQ: FLGC).

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — California Governor Vows to Reform State Marijuana Taxes

Last week, California Gov. Gavin Newsom made an announcement that was welcomed by the marijuana industry. During a news conference after revealing his 2022–2023 budget estimates, Newsom stated that he planned to revisit marijuana taxes so that the cannabis market could be stabilized.

During that news conference, Newsom also stated that he planned to make municipalities across the state wake up to the immense potential of allowing marijuana retail businesses to operate within their jurisdictions in order to squeeze out black market operators.

However, the governor didn’t provide any details regarding the approach that he would use to enact the needed tax reforms as well as how to get more retail outlets open. Some analysts think that Newsom will include a grant program in the state budget so that businesses in the cannabis space can receive the help they need to become formal and adhere to the existing marijuana laws in California. Industry watchers also say that it is likely that any changes to the cannabis tax regime will be made through the use of a standalone law presented to the legislature.

For such a tax bill to pass, support from two-thirds of the lawmakers in both legislative chambers is required, and this will not be an easy feat given that more than one tax reform bill is likely to be tabled this year. What is likely to be easier to implement is a grant program. Newsom’s administration has so far supported a number of grant initiatives, such as one to promote social equity in the cannabis industry and another to enable local governments to process more cannabis licenses.

Newsom’s announcement comes at a time when there is growing unease about the future of the state marijuana industry given the high taxes imposed, opposition from many municipalities and a thriving black market. Some activists have even gone so far as to predict that the sector could collapse in a year if urgent steps aren’t taken to reform the tax policy applicable to cannabis products. These activists say the biggest victims are likely to be small businesses, especially those owned or operated by minority groups, since these small businesses are already burdened by numerous disadvantages, such as limited capitalization.

Graham Farar, president of Glass House Group, remarked that Newsom had zeroed in on the two main things that the marijuana industry needed. These two things are lower taxes that would allow licensed operators to compete favorably with the black market, and more outlets in the retail segment so that more products made can be sold legally.

If these needed reforms are enacted, the entire sector, including companies such as American Cannabis Partners, will benefit from a regulatory landscape that is a tad more favorable to the growth of the industry.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Featured in EDGE Podcast Interview

Lexaria Bioscience (NASDAQ: LEXX) CEO and chair Chris Bunka is the guest on a recent episode of the EDGE podcast. Hosted by entrepreneur and angel investor Brandon C. White, the EDGE is a podcast series focused on providing a playbook for business owners that takes a look at the inner game of building a successful business and giving listeners the edge to become smarter, healthier and richer. Lexaria Bioscience is a global innovator in drug-delivery platforms. During the interview, Bunka shared his background and the journey that led him to Lexaria. He also talked about Lexaria’s business model and the company’s focus on improving the delivery of active pharmaceutical ingredients, vitamins and minerals. In addition, he discussed Lexaria’s ongoing efforts to leverage its innovative drug-delivery platform to improve the effectiveness of orally delivered compounds. “Lexaria Bioscience is a tech company, and we provide really, really interesting solutions to the pharmaceutical industry, as well as nutraceuticals and even delivery of beneficial vitamins and minerals in foods,” said Lexaria Bioscience CEO and chair Chris Bunka in the podcast. “Our technology is all about enabling a much higher fraction and a much smoother delivery of the beneficial substances in the foods you eat and in the drugs you take and, quite frankly, getting them into your bloodstream. With a lot of these compounds and drugs, the vast majority of what you eat or swallow ends up in the toilet, and that’s no good. So we can fix that.”

To view the full interview, visit https://cnw.fm/xmS17

To view the full press release, visit https://cnw.fm/F4s7N

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption with cannabinoids and nicotine by 5 to 10 times as well as reduce time of onset from one to two hours to minutes and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs; nonsteroidal, anti-inflammatory drugs (“NSAIDs”); and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Study Finds That Hemp Compounds Could Block Coronavirus Infection

New research carried out by researchers at the Oregon State University and the Oregon Health and Science University has discovered that some hemp compounds may be able to prevent SARS-CoV-2 from entering cells in the human body. SARS-CoV-2 is the virus that causes the coronavirus infection. The study’s findings were reported in the “Journal of Natural Products.”

Hemp is a strain of the marijuana plant that has been grown for use in various commercial applications. The plant has very small amounts of THC (tetrahydrocannabinol), which is one of the two primary compounds found in cannabis, the other being CBD. Unlike THC, which is a psychoactive that usually induces a high, CBD (cannabidiol) doesn’t possess psychoactive properties. Studies have shown that CBD can help manage depression, anxiety and even seizures.

The researchers discovered that cannabidiolic acid and cannabigerolic acid, which are both compounds found in hemp, can bind to the spike protein that SARS-CoV-2 uses to enter the body, which will help block the virus from infecting individuals. For their study, the researchers conducted an analysis using a mass septectomy-based screening method. Their analysis included different plant-derived compounds that are used as dietary supplements, including licorice, hops, wild yam and red clover. The researchers ranked the compounds based on their affinity to bind with the SARS-CoV-2 spike protein, which led to the discovery of the pair of compounds.

In a statement, Richard van Breemen, the study’s lead researcher, explained that the compounds were abundant in various hemp extracts as well as in the hemp plant, adding that the compounds had a good safety profile in humans, unlike THC, which is a controlled substance. Van Breemen added that the compounds were precursors to hemp-derived substances such as CBG (cannabigerol) and CBD, which are well-known, noting that despite this, the substances weren’t found in many hemp products. The researcher maintained that more studies were needed to discover the right dosage for human consumption of these compounds.

In their report, the researchers highlight that smoking marijuana doesn’t provide any protection from the virus that causes the coronavirus. They explain that the benefit for preventing the infection of cells needs to be derived from cannabinoid acids, which should not be smoked because they are heat sensitive and would be turned into CBD.

A press release from the institution revealed that the research also looked into the effectiveness of these compounds against the alpha, beta and original strains of SARS-CoV-2. However, more recent variants of the coronavirus, such as omicron and delta, weren’t included.

It is exciting to know that so much more about the therapeutic potential of the cannabis products made by established companies such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) is still being discovered and documented. It could take many more years before this versatile plant is fully understood.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.